Goal-directed Enteral Nutritional Perioperative Management

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences

About this trial

This clinical trial aims to determine whether perioperative goal-directed nutritional therapy can prevent postoperative pulmonary and other major complications in malnourished esophageal squamous cell cancer patients. Its main question is whether individualized nutritional therapy can improve short-term surgical outcomes and long-term prognosis. Researchers will compare goal-directed and conventional nutritional therapy to identify differences in morbidities and survival.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-80 years old;

ECOG PS 0~1;

NRS 2002 score ≥3;

Malnutrition diagnosed according to the GLIM criteria;

Disqualifiers

NRS 2002 score < 3;

Upfront surgery without neoadjuvant treatment;

Any comorbidity interferes with the digestion and absorption of ORAL IMPACT®;

Receiving any other nutritional support during the study;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Goal-directed EN therapy

    Dietary supplement

    The participants will be administered a supervised goal-directed nutritional therapy. The enteral nutrition (EN) regimens include homemade meals with or without ORAL IMPACT® according to the daily goal.

  • Conventional EN therapy

    Dietary supplement

    The participants will be administered the conventional nutritional therapy according to the Chinese expert consensus on perioperative nutritional support in enhanced recovery after surgery (2019 edition).

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: Goal-directed enteral nutritional therapyExperimental treatment 1 intervention
Group B: Conventional enteral nutritional therapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Rate of postoperative pulmonary complications

According to the Esophagectomy Complications Consensus Group (ECCG) standardization of complications reporting, pulmonary complications include pneumonia, pleural effusion, pneumothorax, atelectasis, mucous plugging, respiratory failure, acute respiratory distress syndrome, acute aspiration, tracheobronchial injury, and prolonged air-leak.

Time frame
Randomization to three months after surgery
2

Rate of unplanned hospital admissions

Any admission (all cause) for an unforeseen or unplanned (non-elective) cause within 90 days of discharge from an index acute hospital admission.

Time frame
Randomization to three months after surgery
3

Rate of unplanned ICU admission

Any admission (all cause) for an unforeseen or unplanned (non-elective) cause within 90 days of discharge from an index acute ICU admission.

Time frame
Randomization to three months after surgery
4

Overall survival

The time from randomization to death. Any patients lost to follow up or still alive at the time of evaluation are censored.

Time frame
Randomization to five years

Secondary outcomes

1

Rate of postoperative non-pulmonary complications

Non-pulmonary complications according to the ECCG standardization of complications reporting.

Time frame
Randomization to three months after surgery
2

Level of serum prealbumin

Prealbumin, also known as transthyretin, has a half-life in plasma of ∼2 days, much shorter than that of albumin. Prealbumin is therefore more sensitive to changes in protein-energy status than albumin, and its concentration closely reflects recent dietary intake rather than overall nutritional status.

Time frame
Randomization to three months after surgery
3

Body mass index (BMI)

A person's weight in kilograms divided by the square of height in meters.

Time frame
Randomization to three months after surgery
4

Lean body mass

The weight of the body minus the⁣ fat content, representing the amount of⁣ muscle, bone, and organs in the body.

Time frame
Randomization to three months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.